data13F

TSHA – Taysha Gene Therapies Inc

Held by 2 of 60 tracked investors in their latest 13F filing · 1 counted on Most owned (narrow-view filings excluded)

Investors holding2
Combined shares633,852
Combined reported value$3.1M

TSHA chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Polen Capital 0.03 Added 2.9%503,379$2.5MQ3 2026
Paul Tudor Jones narrow view 0.00 New130,473$635KQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view New130,4730.00
Q3 2026Polen Capital Added 2.9%503,3790.00
Q2 2026Polen Capital Added 53.0%489,2190.01
Q2 2026Paul Tudor Jones narrow view Closed00.00
Q1 2026Polen Capital Added 104.2%319,7480.01
Q1 2026Paul Tudor Jones narrow view New143,5750.00
Q4 2025Polen Capital New156,5860.00

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view New130,4730.00
Q3 2026Polen Capital Added 2.9%503,3790.00
Q2 2026Polen Capital Added 53.0%489,2190.01
Q1 2026Polen Capital Added 104.2%319,7480.01
Q1 2026Paul Tudor Jones narrow view New143,5750.00
Q4 2025Polen Capital New156,5860.00

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Paul Tudor Jones narrow view Closed00.00

History

2 peakQ3 2026: 2 tracked investors
Q3 2020: 1 tracked investorsQ2 2024: 1 tracked investorsQ4 2025: 1 tracked investorsQ1 2026: 2 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 2 tracked investors
20202026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Polen Capital503.4K489.2K319.7K156.6K––––
Paul Tudor Jones130.5K–143.6K–––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).